(Q41558354)

3 October 2017

title

Is schizophrenia an immunologic receptor disorder? (English)

1 reference

3 October 2017

1 reference

H. H. Fudenberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6316119

26 September 2023

H. D. Whitten

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6316119

26 September 2023

E. Merler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6316119

26 September 2023

O. Farmati

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6316119

26 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6316119

26 September 2023

publication date

1 September 1983

1 reference

full work available at URL

3 October 2017

https://api.elsevier.com/content/article/PII:0306987783900373?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

https://api.elsevier.com/content/article/PII:0306987783900373?httpAccept=text/plain

26 September 2023

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

26 September 2023

1 reference

3 October 2017

volume

12

1 reference

3 October 2017

issue

1

1 reference

3 October 2017

page(s)

85-93

1 reference

Enkephalins and Endorphins

3 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Some Observations on the Opiate Peptides and Schizophrenia

26 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Implications from studies of the nucleus accumbens: toward a multi-factor theory of schizophrenia

26 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

An anatomy of schizophrenia?

26 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Opiate Receptor: Demonstration in Nervous Tissue

26 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Peptide Neurotransmitters

26 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Morphine and enkephalin: analgesic and epileptic properties

26 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors

26 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Autoantibodies to parathyroid hormone receptor

26 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

The long-acting thyroid stimulator

26 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Myasthenic immunoglobulin accelerates acetylcholine receptor degradation

26 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin

26 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Use of anti-idiotypic antibodies as cell-surface receptor probes

26 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: Possible application to vaccine production

26 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Increased CSF levels of endorphines in chronic psychosis

26 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Naloxone-induced reversal of schizophrenic hallucinations

26 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Cytomegalovirus Antibody in Cerebrospinal Fluid of Schizophrenic Patients Detected by Enzyme Immunoassay

26 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Schizophrenia: Dopamine β-Hydroxylase Activity and Treatment Response

26 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

A peptide-containing fraction in the urine of schizophrenic patients which stimulates opiate receptors and inhibits dopamine uptake

26 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

The behavior of T lymphocytes in schizophrenia

26 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques.

26 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Psychopathology in systemic lupus erythematosus. I. Psychiatric observations

26 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

The Occurrence of Psychiatric Illness in Systemic Lupus Erythematosus

26 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Antibodies Reactive with Neurons in SLE Patients with Neuropsychiatric Manifestations

26 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Serum proteins in acutely psychotic patients

26 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Tgamma cells in systemic lupus erythematosus. Variation with disease activity

26 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Immunoregulatory aberrations in systemic lupus erythematosus

26 September 2023

36

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction

26 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Human B cell activation in vitro: augmentation and suppression by monocytes of the immunoglobulin production induced by various B cell stimulants

26 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Role of lipids in the immune response. I. Localization to a lipid-containing fraction of the active moiety of an inhibitor (SIF) of lymphocyte proliferation

26 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Multiple opiate receptors: emerging concepts.

26 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Association of HLA-Bw44 with chlorpromazine-induced autoantibodies

26 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

Enkephalins--enhancement of active T-cell rosettes from lymphoma patients

26 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/0306-9877(83)90037-3

26 September 2023

Identifiers

1 reference

3 October 2017

1 reference